We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · May 28, 2022

Utilizing Cystatin C for the Detection of Sight-Threatening Diabetic Retinopathy

JAMA Ophthalmology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Ophthalmology
Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy
JAMA Ophthalmol 2022 May 05;[EPub Ahead of Print], S Gurudas, K Frudd, JJ Maheshwari, YR Revathy, S Sivaprasad, SM Ramanathan, V Pooleeswaran, AT Prevost, E Karatsai, S Halim, S Chandra, P Nderitu, D Conroy, S Krishnakumar, S Parameswaran, K Dharmalingam, K Ramasamy, R Raman, C Jones, H Eleftheriadis, J Greenwood, P Turowski

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading